A β 1-15/16 as a marker for γ -secretase inhibition in Alzheimer’s disease
暂无分享,去创建一个
Kaj | D. Holtzman | E. Siemers | S. Paul | R. Dean | R. Bateman | K. Mawuenyega | Wendy C. Sigurdson | H. Zetterberg | U. Andréasson | E. Portelius | P. May | Alexandre Marcil | M. Nutu | Blennow | Bourgeois | Philippe | U. Andreasson | Magdalena Nutu
[1] K. Blennow,et al. A novel pathway for amyloid precursor protein processing , 2011, Neurobiology of Aging.
[2] M. Citron,et al. Alzheimer's disease: strategies for disease modification , 2010, Nature Reviews Drug Discovery.
[3] K. Blennow,et al. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease , 2010, Acta Neuropathologica.
[4] M. Bielefeld-Sévigny. AlphaLISA immunoassay platform- the "no-wash" high-throughput alternative to ELISA. , 2009, Assay and drug development technologies.
[5] A. Fleisher,et al. Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. , 2008, Archives of neurology.
[6] B. de Strooper,et al. 1-(3′,4′-Dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic Acid (CHF5074), a Novel γ-Secretase Modulator, Reduces Brain β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease without Causing Peripheral Toxicity , 2007, Journal of Pharmacology and Experimental Therapeutics.
[7] Henrik Zetterberg,et al. Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. , 2007, Journal of proteome research.
[8] Timothy Harrison,et al. The Novel γ Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) Reduces Amyloid Plaque Deposition without Evidence of Notch-Related Pathology in the Tg2576 Mouse , 2007, Journal of Pharmacology and Experimental Therapeutics.
[9] E. Reiman,et al. Alzheimer's disease a century later. , 2006, The Journal of clinical psychiatry.
[10] David M Holtzman,et al. Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo , 2006, Nature Medicine.
[11] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[12] B. de Strooper,et al. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. , 2003, Neuron.
[13] C. Vigo‐Pelfrey,et al. Characterization of beta-amyloid peptide from human cerebrospinal fluid. , 1993, Journal of neurochemistry.